Mailbag: The State of Value-Based Health Care w/ John Marchica, Darwin Research Group
Episode Summary
After a year of interviews about value-based care, the same things keep coming up. Fee-for-service is still the problem. Payers want to pay less, providers want to bill more. And twenty years in, the people who helped build value-based care are grading it a C-minus.In his first supplemental episode, host John Marchica goes back through the transcripts and pulls out what guests agree on: the problems value-based care is trying to fix, the fixes they keep proposing — mandatory participation, full-risk capitation, payer-provider integration — how it's going so far, and where the real progress is likely to come from, which is the states, not Washington.
Episode Notes
After a year of interviews about value-based care, the same things keep coming up. Fee-for-service is still the problem. Payers want to pay less, providers want to bill more. And twenty years in, the people who helped build value-based care are grading it a C-minus.
In his first solo episode, host John Marchica goes back through the transcripts and pulls out what guests agree on: the problems value-based care is trying to fix, the fixes they keep proposing — mandatory participation, full-risk capitation, payer-provider integration — how it's going so far, and where the real progress is likely to come from.
Tell us how we're doing and take our survey here.
================================================
🎙 ABOUT HEALTH CARE ROUNDS
Health Care Rounds is a weekly podcast developed for health care leaders who are at the forefront of health care delivery and payment reform. Join Darwin Research Group founder and CEO John Marchica as he discusses the latest advancements in health care business news and policy developments.
================================================
CONNECT WITH US:
🌐 Follow Health Care Rounds on LinkedIn
🌐 Follow Darwin Research Group on LinkedIn
📺 Watch Health Care Rounds on YouTube
⚙️ Health Care Rounds is produced by Grippi Media
Welcome to Healthcare Rounds. This is John Marchica, CEO of Darwin Research Group. Today I'm doing something a little bit different. Decided to do a supplemental episode. I've been talking a lot about value-based care over the last, say, several months. And I thought I'm starting to see some themes. As a researcher and who does a lot of research interviews, typically when we're doing a qualitative study, we always say 25 or 30 is that's a good number of respondents for any given kind of qualitative work. But usually around, I don't know, nine, 10, a dozen interviews, you start to see patterns. But folks who are listening to the podcast, maybe sometimes you'll listen to an episode, maybe a few months go by and you don't listen to the next. It's not easy to see the through lines from guest after guest that may be appearing. So what I did is I took the transcripts, printed them out, took out my red pen, admittedly, although not so successfully, I would say, used AI to help organize some of the information. And I came up with really three areas around value-based care to talk about. One is what are the common problems that we're seeing in healthcare in general that value-based care is at least attempting to address? Two, what are the proposed solutions to those problems? Three, what's our scorecard? How are we doing on value-based care so far? And then finally, what are the guests saying? And really, what do I think are the future of what's happening with healthcare and in particular with value-based care? So that's what I'd like to do over the next, I don't know, 10-15 minutes. We'll see how long this goes. But before we get to that, I just want to make a couple of announcements. One is in the show notes, there's a survey. Please take time. It's three minutes. You get a $5 Starbucks gift card. Go in, complete the survey. We're going to be getting the kind of the word out on through LinkedIn and through our weekly news piece that Darwin does, our take, and then I'm the editor of. So there'll be other places you'll see the link, but take the time now and do the survey. Second thing is here's my push. We know that a lot more people are listening to this, a lot more people are watching on YouTube than we actually have ratings and reviews. And I know everybody hears this, anybody who's been listening to podcasts for some time knows that the host is always asking for please make sure to rate and review. And I say the same thing. But the numbers of what we know is happening versus who is actually taking the time to give a rating or review or to follow or subscribe, vast difference. So here's my plea. If you're on Spotify, Apple, YouTube, or even anywhere else, make sure to follow the show and just as important where it's uh a possibility, put in a rating. We'd appreciate a five-star rating, but also appreciate your honest assessment. So now that's out of the way, let's get to what I'm seeing. So, first of all, common problems. And we could list a whole bunch of them, but I'm going to stick to the top ones that came through in say the last interviews. And by the way, actually before I get into this, I just want to pull up and take a look at the list of some of the folks that we've had. So, what prompted me to do this actually is my last interview with Dr. Elliot Fisher from Dartmouth, somebody I know very well. Obviously, I bring up the program and I talk a lot about kind of that Dartmouth model of understanding variation and unwarranted variation in healthcare. That's really kind of what got me inspired to start this company and do the work that I do now at Darwin Research Group. But Elliot was one of the pioneers. And so after having all of these conversations, I was like, eh, maybe I should do a little review. So anyway, I'm looking here at the guest list, Elliot Fisher from Dartmouth, Dr. Tim Ferris from Inner Systems. He was one of the guys that was there in the very, very beginning. Michael Chernoby from Harvard is, I don't want to say favorites, but he's absolutely one of the leading researchers out there on health policy and then specifically things like Medicare Advantage, Don Calcegno, Values Edge, formerly with Advocate Healthcare, David Snow with Cedar Gate. I'm just kind of going down the list here. Greg Weisman from CareMore, David Shulkin, a former VA guy, secretary, David Carmouche, who's always appreciative on both sides having him on the show. So there's a lot of folks, and I could go on, but a lot of people have weighed in on this from CEOs, entrepreneurs, policy researchers, academics, people in the seat now delivering care. And so that kind of frames everything that I'm saying. I guess I should have said that up front, but this is first time I'm doing this alone speaking into the mic, so hopefully you'll cut me some slack. Anyway, back to the common problems that we're seeing. First and foremost, undoubtedly, and everybody knows this, our fee-for-service system and the way that we finance healthcare is at the root cause of many of the problems that we see in healthcare. We've been trying to fix this for years and years, and people say we got to do Medicare for all, or the Affordable Care Act and Obamacare, that was one of the things that was trying to, at least on the margins, influence this fee-for-service system. But it causes all kinds of problems, whether it's excess usage of healthcare services, whether it's providing low quality services, things that don't really generate a bunch of impact, but but they put money in the pockets of providers. We can go on and on about this, but I think the number one unifying theme and problem that virtually everybody says, whether it's an entrepreneur to a government, to researchers, says fee for service is the problem. And that's related to things like over-treatment and low value care, as I said. But also related to that is just this aligned incentive structure between payers and providers. And I think back to the Don Calcegno and the way that he described it is look, it's very simple when you understand this gap framework. Payers optimize for paying less and providers optimize for billing more. It's as simple as that. And it's not necessarily that either side is wrong, it's just the system that we've set up. And that also relates to, and I keep coming back to the money here. This is different sides of a coin or shades of a color. And that is the sort of the overall financialization of healthcare. And this is something that Elliot Fisher talked a lot about. And I think we probably have some areas of agreement and then other areas of disagreement where I believe that entrepreneurship, that the incentive structure around, let's say, discovering new drugs or new technologies, that you kind of need that profit motive in there. It's baked into our American system. It's the way that we think. And so I it's hard for me to divorce that part of the equation and say we shouldn't have any kind of financial reward structure for innovation. And I'm not saying that's what Elliot said. It's just that he came out pretty strongly. And maybe there's a little bit of defensiveness here. A lot of us work in and around healthcare. Darman Research Group, for example, we study healthcare systems and do advice and strategy and things like that. We wouldn't be around if there weren't any kind of financial incentive or financial motive. So that's a tough one. But I think what he's talking about is this hyper-financialization or being so focused on making money in some cases that folks may forget that that what we're all about is improving the quality of life, improving health care, improving end-of-life care, all of these things that are big questions that get tangled up in the finances. So I guess that's probably enough on money, but a couple more thematic issues of common problems. Virtual collapse in rural health care. It's just getting worse. If you're out in the sticks, which is, as I pointed out, which is most of America, when you drive across the country, it's small town to small town, you just don't have access to the same level of services that you do in the big cities. You often don't have the same kind of internet access that you do in the larger cities and say metropolitan areas. And while technology can address a lot of these issues, can't address all of them. So how do we address rural care? And then a couple of other things I would say is that healthcare fragmentation, which is related to, but is not just about finances, this overall issue of fragmentation is, I believe, it's kind of the logic of what an integrated delivery system is or should be. And you want to be able to have all elements of care being prov being under one roof or at least some level of connection. And when I think all of us, I should say, we've all had problems with care fragmentation. You go to you go to your doctor and that doctor isn't sure what product that he or she can prescribe because maybe they don't have access to certain lists, or you have a procedure done and they don't have access to your medications, or you go see a specialist and they don't have clear eyesight into primary care. These are the easy examples, but fragmentation is a major problem that at least the IDN framework tries to address. Whether they're successful at it really depends on the IDN. So those are common problems. And then I would say the solutions that we see, the biggest one, which is probably going to get people maybe a little bit upset, because we like choice, certainly in this country, and that is making whatever these solutions are mandatory. So if you're going to do an ACO, have mandatory participation. If you're going to do a bundle, make it mandatory. Why the basic logic of that is that voluntary programs let organizations kind of retreat back to fee for service and to what's comfortable. And when value-based care gets difficult, when you're on the hook for certain things, when you're incurring more risk, a lot of people want to avoid that. So if you have mandatory participation in these models, you really are kind of forced to move towards better care, better outcount comes at lower costs. Second thing I would say most common proposed solution is related to, but is not the same thing, which is full risk capitation perspective bundles. So in a capitated model, it's that per member per month payment system rather than fee for service. Capitation has been around forever. It's a hallmark of the old managed care plans. And the knock on managed care back in the day with these capitated arrangements was well, if you're just paying per member per month or if there's a fixed rate, then you have an incentive to deny care, right? That's like the biggest knock on managed care from the 80s, 90s, and even into the 2000s. And in the value-based framework or in the triple aim, quantum aim, what we're trying to do is have that certainty, have that capitated model, but where there's also there are also incentives to ensure that you're providing good quality as well. And then a few others proposed solutions. I think we've heard a lot about payer provider integration. I don't think there's 100% agreement on that. Dr. Robert Pearl, who's been on the show a couple of times at this point, has argued for that Kaiser model, whether it's Kaiser or anybody else, but that payer provider integration is what we really need. And it makes sense. Why? Because I think that a lot of folks make this total cost of care argument, right? Great example that's been used time and again is when a drug provides a lot more benefit than, let's say, what it's indicated for. You have, say, a diabetes treatment that takes care of the underlying disease or at least mollifies its progress progression, but there are a whole host of other outcomes there that need to be recognized. And if you look at the total patient journey, the total cost, the benefit that you receive is much more than, let's say, that individual benefit of managing that one specific disease. When you have that fully integrated payer provider model, there is that incentive to look at the whole picture. When you have a disjointed model and you have, let's say, a United Healthcare on the outside, and then somebody getting care at, I don't know, Sutter Health. On the other hand, that that fragmentation and not having that integration means that Sutter is going to be operating in their best interest. As a payer, United Healthcare is going to be operating in their interest, a lot of times very short-term time horizons. And maybe they're not recognizing the full value of a given treatment because they're that integration isn't there. And there are, of course, hybrid models out there as well. I guess the final piece that I would say is I'm resisting talking about AI all throughout this because AI seems to be on everybody's mind and it isn't the solution to everything. But one of the concepts that comes up frequently, and I talk about this a lot too, which is a lot of healthcare or a lot of what we think of outcomes in healthcare happens in between visits, in between surgeries, in between interventions. It's how you're living your life. It's how you're, if you're taking your medications. And AI, one of the promises, and I think this is certainly a potential solution, AI can help bridge that gap and other kinds of analytics that will give the provider or the payer or the integrated system an ability to have a window into the full spectrum of what that patient's care journey looks like. AI being a component of that. So let's talk about an assessment of value-based care. First of all, I think we all agree. It seems like it comes up on in in nearly every episode when we talk about it. Value-based care is a terrible moniker, terrible way to describe what it is that that we're shooting for. If you ask your average consumer or patient and just kind of talk to them, would you like to get value out of healthcare? Like, what are you talking about? Of course I want value. They think that they get, they're always thinking in these terms. And maybe it makes them think, maybe I'm not getting good value, but it's just one of those terms that it's like population health. I think it's getting long in the tooth. So there's that. I think people universally agree. Not a great term. I don't know that anybody's come up with anything better. But where are we today? Don Calcagno says literally inning one, inning two. We're really, despite the fact that we're at least 20 years, 20, 25 years into this journey, certainly the last decade much more intensively, we're we've got a long way to go. We have not seen the kind of benefits, whether that's in terms of outcomes or substantially reduced costs. It's just the framework is there and people think about it, but we just haven't seen the results. And I was kind of going back to my Elliot Fisher interview, kind of surprised. But then again, knowing Elliot, maybe I shouldn't have been so surprised when he said disappointed. I think he gave where we are with value-based care today, kind of like a C-glass totally empty on the transformation that he hoped for years and years ago. Dr. Carmouche graded it as C- as well. I would say that Dr. Cherno is also very skeptical throughout that interview in talking about the success of value-based care. Maybe the only outlier I can think of recently was Dr. Dr. Ferris, Dr. Tim Ferris, who pointed out that if ACOs, for example, were able to achieve a 2% savings in healthcare, it doesn't sound like a lot, but when you balance that against healthcare inflation, and you you look at really what it was seeking to accomplish, I think he was very optimistic in his assessment. Yes, we're early innings, yes, we have a long way to go. But in terms of assessing where we are today, he was probably the most positive of anyone that I talked to on healthcare rounds. So though that's the assessment. What's my assessment? I think I'm somewhere in between. I know that's going to sound wishy-washy, but I do share Tim's enthusiasm that we should celebrate the wins that we've had. It's a very complex system and complex set of problems that we're trying to fix. And when you take an approach like, say, Obamacare and the Affordable Care Act, everyone acknowledged that it was one of those marginal improvements. It was not going to be, let's say, when Medicare was authorized in the 60s, it was not going to be that kind of a major deal. But in the political environment and what could have been done, it was the most I think that could have been done at the time. So I think that we've done pretty well. But I also think that something else I've mentioned on healthcare around multiple times, when I go back to the early days of going to the ACO conferences and value-based care conferences, the level of enthusiasm was infectious. And I think that most of the people that I met and talked to, most of them who were physicians, physician leaders, who really felt like we torn turned the corner on how we viewed caring for patients, paying for delivery or paying, paying for healthcare, how we were delivering healthcare, that we were at a big point. We were at a point in time where we were going to do really big things. And that was what I remembered. And there were a couple of years there where I felt like I was just going to all these conferences and just staying up to date on what was the latest at the time when all of these changes were really being implemented and really taking place at scale. So I'd say that I'm somewhere in the middle. So let's to wrap this up, what final piece is what did we learn about what are folks saying about what's to come with value-based care? What are some future project projections? And there's a bunch of these things, but I'm going to really focus on one or two, maybe three. The first one, which I think is absolutely the most important and is easy to be missed. And that is that we need to frame this issue of value-based care and how we think about value-based care versus the old fee for service world as a both and problem. In other words, it's not that we're moving to value-based care and we think that the old system is just going to completely go away. It will not replace. There will be times when fee for service medicine makes absolute sense. And there will be times when doing things like bundles and ACOs are the right approach. That we need, in other words, we need to view value-based care as maybe a tool or one framework among several that is going to get us to where we want to go. I think a lot of the debate, and sometimes I'll admit, the way that I think about it, it just assumes that value-based care is going to be 100% of the system. That is absolutely not the case. Now, I will say that we do know that CMS at Medicare for some time has been shooting for capitation. That's for all lives under capitation, so that they can have predictability and in in their health care costs from year to year. That's probably again the most important thing. A couple of other things that I think to look towards is that we're really going to see these reforms or these improvements around value or new payment models or real innovation in care delivery. That's going to happen at the state level, not at the national level. I don't think that's a controversial position. I think we'd all love to have some form of change, regardless of what your political perspective is, whether you want everything to be solved by the private markets and the private sector, or you think that government needs to take a larger role. The idea that anything is going to happen nationally is a fantasy. And so that's why we need to look to the state of Maryland and what they've done there. We need to look at experimentation that's happened in Louisiana and in Vermont and California and Washington. What lessons can we learn at the state level? What can be implemented at the state level? It's just a lot easier to get your arms around. It also, I think, is a nod to the fact that all health care is local. It's an old saying, but I think it's very true. When you try to nationalize or mandate something nationally, it becomes really hard to say what makes sense in rural Illinois is the same thing that makes sense here in Maricopa County, Arizona. And then finally, so there's those two. And then finally, I would say that the jury is out on AI. I think everybody would agree with that statement. There's a lot of hesitation. People see a lot of promise. I'm intentionally avoiding not doing every healthcare rounds episode on AI. It is just so hot on everybody's minds. But I think if I could summarize what we've heard across episodes, and that is there's a lot of promise for the technology to around workflow, around repetitive tasks, around getting better information out of, let's say, note-taking in the exam room handled by AI and getting better information out of that. But I think where everybody universally, at least the guests that I've had on healthcare arounds, universally would say we cannot let AI replace that physician or provider, nurse, pharmacist, that relationship with the provider, the clinician, and the patient. It is so important. I think personally, one of the reasons that I make sure that I go in for my annual checkups, and I don't really dread going to the doctor much anymore, is I've got a good relationship with my primary care doctor. And I don't want to say that I necessarily look forward to my physicals, but I don't dread them. And I know that if I have any kind of issue or problem that I want to talk to, I'm in this world, excuse me, of health care and healthcare service research, right? I have access to a lot of data, but at the end of the day, I trust that relationship with my primary care doc. I'm not going to have that same level of trust with, say, Claude or ChatGPT. It is really important. I think everyone would argue for maintaining some level of human relationship between the clinician and the patient. So a lot more than I could cover for now, but I wanted to keep this brief or certainly shorter than the interviews that I conduct. If you have any thoughts, please make sure to take the survey. As I said, rate and review Spotify, Apple, follow us on YouTube. Look, my email is jm at darwinresearch.com. Feel free to send your thoughts. Feel free to send your questions. If you'd like to have maybe do a mailbag episode, send them my way, attributed or not attributed. That's up to you. But I hope this has been valuable for you as a listener. And I look forward to seeing you on the next episode of Healthcare Rounds. And as I say, closing every episode, we'll see you next round.
Recommended Next
Subscribe to Our Take
Sign up for Our Take Newsletter: highly curated, expert weekly strategic insights for health care executives.










